Big Data, and the derived analysis techniques, such as artificial intelligence and machine learning, have been considered a revolution in the modern practice of medicine. Big Data comes from multiple sources, encompassing electronic health records, clinical studies, imaging data, registries, administrative databases, patient-reported outcomes and OMICS profiles. The main objective of such analyses is to unveil hidden associations and patterns. In cardiac surgery, the main targets for the use of Big Data are the construction of predictive models to recognize patterns or associations better representing the individual risk or prognosis compared to classical surgical risk scores. The results of these studies contributed to kindle the interest for personalized medicine and contributed to recognize the limitations of randomized controlled trials in representing the real world. However, the main sources of evidence for guidelines and recommendations remain RCTs and meta-analysis. The extent of the revolution of Big Data and new analytical models in cardiac surgery is yet to be determined.

Big Data in cardiac surgery: real world and perspectives / A. Montisci, V. Palmieri, M.T. Vietri, S. Sala, C. Maiello, F. Donatelli, C. Napoli. - In: JOURNAL OF CARDIOTHORACIC SURGERY. - ISSN 1749-8090. - 17:1(2022), pp. 277.1-277.11. [10.1186/s13019-022-02025-z]

Big Data in cardiac surgery: real world and perspectives

F. Donatelli;
2022

Abstract

Big Data, and the derived analysis techniques, such as artificial intelligence and machine learning, have been considered a revolution in the modern practice of medicine. Big Data comes from multiple sources, encompassing electronic health records, clinical studies, imaging data, registries, administrative databases, patient-reported outcomes and OMICS profiles. The main objective of such analyses is to unveil hidden associations and patterns. In cardiac surgery, the main targets for the use of Big Data are the construction of predictive models to recognize patterns or associations better representing the individual risk or prognosis compared to classical surgical risk scores. The results of these studies contributed to kindle the interest for personalized medicine and contributed to recognize the limitations of randomized controlled trials in representing the real world. However, the main sources of evidence for guidelines and recommendations remain RCTs and meta-analysis. The extent of the revolution of Big Data and new analytical models in cardiac surgery is yet to be determined.
Artificial intelligence; Big Data; Cardiac surgery; Coronary revascularization; Heart failure; Left ventricular assist devices; Machine learning; Valvular heart diseases
Settore MED/23 - Chirurgia Cardiaca
29-ott-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
s13019-022-02025-z.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 921.35 kB
Formato Adobe PDF
921.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/949611
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact